Comparison of lisdexamphetamine and and methylphenidate in adult ADHD
Phase 2
Recruiting
- Conditions
- ADULT ADHD.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20221018056238N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Age more than 16 years
Diagnosis of adult attention deficit hyperactive disorder based on DSM-5
Diagnosis of adult attention deficit hyperactive disorder based on DIVA-5
Exclusion Criteria
Alcohol and other substance us
History of Bipolar or psychotic disorders
Other psychiatric disorders such as MDD or Autism spectrum disorder
Pregnancy or Lactation
hypersensitivity to drugs used in this study
Neurologic disorders or severe Hepatic or Renal disease
BMI less than 18
Dependency to drugs ex. Benzodiazepines MDMA and other substances
History of not responding to stimulants
Use of any other drug with effects on CNS
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure includes changes in scores of BDEFS and WHOQOL scores from the beginning to the end of study. Timepoint: before intervention then 2,4,8 weeks after intervention. Method of measurement: Questioner of Barkley deficits in executive functioning scale for adults , WHO Questioner of quality of life , Clinical global impression GCI Questioner.
- Secondary Outcome Measures
Name Time Method